MILFORD, Mass. & FRANKFURT, Germany--(BUSINESS WIRE)--Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) treatment, today ...
There is little information on the effectiveness of emergency department (ED) observation unit (OU) heart failure (HF) therapy. The authors' objective was to evaluate outcomes after implementation of ...
MILFORD, Mass.--(BUSINESS WIRE)--Reprieve Cardiovascular, Inc., a development-stage company pioneering an intelligent automated diuretic and fluid management approach for acute decompensated heart ...
Expert Rev Cardiovasc Ther. 2012;10(2):177-189. The DOSE study demonstrated that higher doses of diuretics are more efficacious in relieving congestion than a low-dose strategy. This was associated ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Considerable sex disparities are reported in elderly patients with HFmrEF/HFpEF, with male sex and older age predicting poor outcomes.
Intravenous loop diuretics are recommended for fluid overload in acute decompensated heart failure. A new study examined whether adding acetazolamide could improve decongestion. New research findings ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
A specialized cardio-nephrology service is feasible and could provide interdisciplinary care for patients with cardiovascular-kidney-metabolic syndrome, according to study data published in Kidney360.
The meeting will feature sessions on AI in heart failure, advanced LVAD technologies, cardiac xenotransplantation, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results